all AI news
Simmunome and Mila Announce Partnership to Advance AI in Drug Development
MONTREAL, November 21, 2023 – Simmunome Inc., a Montreal-based techbio company leveraging generative artificial intelligence (AI) to increase the predictability of clinical drug development announces today its partnership with Mila – Quebec AI Institute, the world’s largest academic deep learning research center. Simmunome integrates multi-omic data to generate in silico disease models that accurately capture...
The post Simmunome and Mila Announce Partnership to Advance AI in Drug Development appeared first on Mila.
academic advance artificial artificial intelligence center clinical data deep learning development drug development generate generative generative artificial intelligence institute intelligence partnership research techbio world